Market Place
Sourcing Support
How to Choose the Right CDMO Partner: Key Factors to Consider
20 Nov 2024 //
PRESS RELEASE
Bachem’s Sustainable TIDES Manufacturing
30 Oct 2024 //
PRESS RELEASE
Bachem at Swiss Technology Award 2024
20 Sep 2024 //
PRESS RELEASE
Bachem Reports Slight H1 2024 Sales Growth And Confirms Full-Year Outlook
25 Jul 2024 //
PRESS RELEASE
Incident On Construction Site Of Bachem In Bubendorf
28 May 2024 //
PRESS RELEASE
Voices On Bachem’S Innovation Culture
30 Apr 2024 //
PRESS RELEASE
Bachem Annual General Meeting 2024
24 Apr 2024 //
PRESS RELEASE
Streamlining Project Management For Successful Pharma Clinical Trials
15 Mar 2024 //
PRESS RELEASE
Bachem continues to grow and increases dividend
07 Mar 2024 //
PRESS RELEASE
Our approach to remaining a leader in TIDES
01 Mar 2024 //
PRESS RELEASE
ISO recertification of Bachem`s St Helens site in the UK
16 Feb 2024 //
PRESS RELEASE
A Conversation With The Founders Of Chromacon
01 Feb 2024 //
PRESS RELEASE
The era of large-scale peptide & oligo purification with MCSGP has begun
10 Jan 2024 //
PRESS RELEASE
Jérôme Kaeslin receives ETH medal for his outstanding dissertation
01 Dec 2023 //
PRESS RELEASE
Elena Zakharova Wins Cancer Drug Discovery Research Award
15 Nov 2023 //
PRESS RELEASE
AmbioPharm Appoints Industry Veteran Brian Gregg as CEO
02 Oct 2023 //
BUSINESSWIRE
Change in the Bachem Corporate Executive Committee
15 Sep 2023 //
PRESS RELEASE
Glucagon-like peptide 1 (GLP-1)
14 Sep 2023 //
PRESS RELEASE
How to increase sustainability for large-scale peptide API purification ?
24 Aug 2023 //
PRESS RELEASE
How can pharma and biotech benefit from strategic Alliances?
11 Aug 2023 //
PRESS RELEASE
Bachem increases sales slightly in the first half of 2023
27 Jul 2023 //
PRESS RELEASE
Great To Be Part Of A Company That Stays True To Its Roots!
19 Jul 2023 //
PRESS RELEASE
IEA Environmental Excellence Award 2023
14 Jul 2023 //
PRESS RELEASE
Meet Iain Pritchard – New Site Manager at Bachem St
03 Jul 2023 //
PRESS RELEASE
Solid Phase Peptide Synthesis
05 Jun 2023 //
PRESS RELEASE
Purification – A Bottleneck For Large-Scale Manufacturing Oligonucleotide API
12 May 2023 //
PRESS RELEASE
Manufacturing complex Peptide APIs
25 Apr 2023 //
PRESS RELEASE
Bachem Annual General Meeting 2023
20 Apr 2023 //
PRESS RELEASE
Meet Bachem - Interview with Gilles Parmentier
13 Mar 2023 //
PRESS RELEASE
Bachem Raises CHF 108.1M Through Capital Increase To Accelerate Growth Plans
10 Mar 2023 //
PRESS RELEASE
Bachem Launches An Bookbuilding For Placement of Up To 1.25 Million New Shares
09 Mar 2023 //
PRESS RELEASE
Bachem Signs Agreement For The Development and Supply of Peptides
03 Mar 2023 //
PRESS RELEASE
Bachem Innovative Approaches for Large-Scale Peptide Production
17 Feb 2023 //
PRESS RELEASE
New mass spectrometry (MS) characterization for an accurate identification of oligonucleotide impurities
20 Jan 2023 //
PRESS RELEASE
New Site Manager at Bachem Headquarters: Meet Frank Dettner
02 Jan 2023 //
PRESS RELEASE
Bachem signs long-term follow-on contract for peptides
16 Dec 2022 //
PRESS RELEASE
On the way to greener SPPS: Replacing DMF
07 Dec 2022 //
PRESS RELEASE
Inspiring today`s youth for science and technology - Bachem
25 Nov 2022 //
PRESS RELEASE
Bachem hosts webinars on high-resolution MS characterisation of oligonucleotides
24 Nov 2022 //
PHARMACEUTICAL NETWORKING
Bachem Welcomes New Site Manager in Torrance: Luckner
14 Nov 2022 //
PRESS RELEASE
Bachem Innovates its Manufacturing Capabilities
14 Oct 2022 //
CHEMANAGER
A world of virtual reality: entering the metaverse with Bachem 360
13 Oct 2022 //
PRESS RELEASE
Our Key Ingredients For A Successful Oligonucleotide Drug Development
06 Oct 2022 //
PRESS RELEASE
Bachem Expands Presence In Northwestern Switzerland. New Production Site Planned In Sisslerfeld
05 Oct 2022 //
PRESS RELEASE
Bachem Signs Large Volume Contracts For Peptides
20 Sep 2022 //
PRESS RELEASE
Change to the IT Leadership
09 Sep 2022 //
PRESS RELEASE
Bachem with slight decline in sales to CHF 234.9 million
25 Aug 2022 //
PRESS RELEASE
Addition to the Bachem leadership team
05 Aug 2022 //
PRESS RELEASE
Interview With Philipp Karbach, COO/CFO Of Amw
27 Jul 2022 //
PRESS RELEASE
Bachem’S Journey To Industry 4.0
11 Jul 2022 //
PRESS RELEASE
Innovation Transforming Oligonucleotide Manufacturing
11 May 2022 //
PRESS RELEASE
Bachem, Lilly Enter Strategic Oligonucleotide API Pact
11 May 2022 //
CONTRACTPHARMA
Bachem Earns Gold Medal Sustainability Rating from EcoVadis
05 May 2022 //
PRESS RELEASE
Bachem Annual General Meeting 2022
27 Apr 2022 //
PRESS RELEASE
Bachem Enters Collaboration with Lilly
26 Apr 2022 //
PRESS RELEASE
A passion for shaping the future of Bachem
01 Apr 2022 //
PRESS RELEASE
Bachem Holding`s Earnings Are Of Questionable Quality
26 Mar 2022 //
SIMPLYWALL
Bachem achieves sales of half a billion Swiss francs
18 Mar 2022 //
PRESS RELEASE
Cell-penetrating peptides: a delivery system for oligonucleotides
10 Mar 2022 //
PRESS RELEASE
Bachem in Oligonucleotides: Interview with Seamus White
25 Feb 2022 //
PRESS RELEASE
